4.7 Review

Four-repeat tauopathies

Journal

PROGRESS IN NEUROBIOLOGY
Volume 180, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pneurobio.2019.101644

Keywords

4R-tauopathy; Microtubule-Associated protein tau; Progressive supranuclear palsy; Corticobasal degeneration; Argyrophilic grain disease; Glial globular tauopathy; Alzheimer's disease

Categories

Funding

  1. German Federal Ministry of Education and Research [BMBF: 01KU1403A EpiPD, 01EK1605A HitTau]
  2. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC 2145, 390857198]
  3. DFG [HO2402/6-2, HO2402/18-1]
  4. NOMIS foundation (FTLD project)
  5. EU/EFPIA/Innovative Medicines Initiative [2] Joint Undertaking (IMPRIND grant) [116060]

Ask authors/readers for more resources

Tau is a microtubule-associated protein with versatile functions in the dynamic assembly of the neuronal cytoskeleton. Four-repeat (4R-) tauopathies are a group of neurodegenerative diseases defined by cytoplasmic inclusions predominantly composed of tau protein isoforms with four microtubule-binding domains. Progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease or glial globular tauopathy belong to the group of 4R-tauopathies. The present review provides an introduction in the current concept of 4R-tauopathies, including an overview the neuropathological and clinical spectrum of these diseases. It describes the genetic and environmental etiological factors, as well as the contemporary knowledge about the pathophysiological mechanisms, including post-translational modifications, aggregation and fragmentation of tau, as well as the role of protein degradation mechanisms. Furthermore, current theories about disease propagation are discussed, involving different extra cellular tau species and their cellular release and uptake mechanisms. Finally, molecular diagnostic tools for 4R-tauopathies, including tau-PET and fluid biomarkers, and investigational therapeutic strategies are presented. In summary, we report on 4R-tauopathies as overarching disease concept based on a shared pathophysiological concept, and highlight the challenges and opportunities on the way towards a causal therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available